NCT00407979View on ClinicalTrials.gov

Comparison of Cathelicidin Expression in Skin and Saliva in Patients With Atopic Dermatitis and Psoriasis

CompletedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions
Atopic DermatitisPsoriasis
Trial Locations (2)

80206

National Jewish Health, Denver

92161

University of California, San Diego, San Diego

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00407979 - Comparison of Cathelicidin Expression in Skin and Saliva in Patients With Atopic Dermatitis and Psoriasis | Biotech Hunter | Biotech Hunter